Literature DB >> 21255829

Combination therapy for visceral leishmaniasis.

Johan van Griensven1, Marleen Boelaert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21255829     DOI： 10.1016/S0140-6736(10)62237-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series.

Authors:  Rakesh Kumar; Vidya Nand Rabi Das; Roshan Kamal Topno; Biplab Pal; Adnan Imam; Kanhaiya Agrawal; Anima Singh; Krishna Murti; Chandra Shekhar Lal; Neena Verma; Pradeep Das; Krishna Pandey
Journal:  Pathog Glob Health       Date:  2016-11-22       Impact factor: 2.894

2.  Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar.

Authors:  P Malaviya; E Hasker; R P Singh; J P Van Geertruyden; M Boelaert; S Sundar
Journal:  Trop Med Int Health       Date:  2012-12-20       Impact factor: 2.622

3.  Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar).

Authors:  Viroj Wiwanitkit
Journal:  Ther Clin Risk Manag       Date:  2012-06-22       Impact factor: 2.423

4.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

Review 5.  Nanostructured delivery systems with improved leishmanicidal activity: a critical review.

Authors:  Natascia Bruni; Barbara Stella; Leonardo Giraudo; Carlo Della Pepa; Daniela Gastaldi; Franco Dosio
Journal:  Int J Nanomedicine       Date:  2017-07-26

Review 6.  The enemy within: Targeting host-parasite interaction for antileishmanial drug discovery.

Authors:  Suzanne Lamotte; Gerald F Späth; Najma Rachidi; Eric Prina
Journal:  PLoS Negl Trop Dis       Date:  2017-06-08

7.  Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India.

Authors:  Vishal Goyal; Sakib Burza; Krishna Pandey; Shambhu Nath Singh; Ravi Shankar Singh; Nathalie Strub-Wourgaft; Vidya Nand Rabi Das; Caryn Bern; Allen Hightower; Suman Rijal; Temmy Sunyoto; Fabiana Alves; Nines Lima; Pradeep Das; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2019-09-26

8.  Relapse of visceral leishmaniasis in an HIV-infected patient successfully treated with a combination of miltefosine and amphotericin B.

Authors:  Shauna McQuarrie; Ken Kasper; Dana C Moffatt; Daniel Marko; Yoav Keynan
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

9.  Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India.

Authors:  Vishal Goyal; Raman Mahajan; Krishna Pandey; Shambhu Nath Singh; Ravi Shankar Singh; Nathalie Strub-Wourgaft; Fabiana Alves; Vidya Nand Rabi Das; Roshan Kamal Topno; Bhawna Sharma; Manica Balasegaram; Caryn Bern; Allen Hightower; Suman Rijal; Sally Ellis; Temmy Sunyoto; Sakib Burza; Nines Lima; Pradeep Das; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2018-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.